Elevated liver enzymes are a common finding on routine bloodwork and can occur for many different reasons, ranging from temporary changes to metabolic, medication-related, autoimmune, infectious, or other medical conditions.

Two commonly measured enzymes are ALT (alanine aminotransferase) and AST (aspartate aminotransferase). ALT is found predominantly in the liver, while AST is also present in skeletal muscle, the heart, and other tissues. When cells are injured or stressed, these enzymes can be released into the bloodstream, resulting in higher levels on laboratory testing.

An abnormal result does not necessarily mean that the liver is failing or permanently damaged. However, persistent elevated liver enzymes should not simply be ignored. Understanding the pattern of abnormalities, medical history, medications, metabolic health, and other laboratory findings can help identify the underlying cause.

What Causes Elevated Liver Enzymes?

There are many potential causes, and sometimes more than one factor is involved.

Common causes and considerations include:

• Metabolic dysfunction-associated steatotic liver disease (MASLD)
• Alcohol use
• Prescription and over-the-counter medications
• Herbal and dietary supplements
• Viral hepatitis, including hepatitis B and C
• Autoimmune liver disease
• Hemochromatosis
• Wilson disease
• Alpha-1 antitrypsin deficiency
• Thyroid disorders
• Celiac disease
• Muscle injury or strenuous exercise
• Biliary or gallbladder disorders

Certain acute conditions can cause much more dramatic increases in liver enzymes, including severe drug-induced liver injury, acetaminophen toxicity, acute viral hepatitis, and reduced blood flow to the liver.

The degree and pattern of elevation matter, which is why liver test abnormalities should be interpreted in clinical context rather than viewed as isolated numbers.

Elevated Liver Enzymes and Metabolic Health

One of the most common causes of chronically elevated ALT and AST is metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease or NAFLD.

MASLD occurs when excess fat accumulates in the liver in association with metabolic risk factors.

These may include:

• Insulin resistance
• Type 2 diabetes or prediabetes
• Elevated triglycerides
• Abnormal cholesterol patterns
• High blood pressure
• Increased abdominal or visceral fat
• Overweight or obesity

However, MASLD can also occur in people who are not overweight, so body weight alone does not determine risk.

Insulin resistance can promote increased delivery and production of fatty acids within the liver, contributing to hepatic fat accumulation and metabolic stress.

ALT may be elevated in MASLD, but an important point is that normal liver enzymes do not rule out fatty liver disease or significant liver fibrosis.

This is one reason liver health should be evaluated in the context of overall metabolic health rather than relying solely on ALT and AST.

An Integrative Perspective on Elevated Liver Enzymes

An integrative approach does not replace conventional evaluation of abnormal liver tests. Rather, it looks more broadly at factors that may be contributing to liver and metabolic health while ensuring that potentially serious causes are appropriately investigated.

This may include examining metabolic health, nutrition, alcohol intake, medications and supplements, sleep, physical activity, gastrointestinal health, and other medical conditions.

The goal is not simply to “lower the numbers.” It is to understand why the liver enzymes are elevated and address modifiable contributors when possible.

1. Insulin Resistance and MASLD

Insulin resistance is closely associated with MASLD and is an important consideration when evaluating unexplained liver enzyme elevations.

A broader metabolic assessment may include:

• Fasting glucose
• Hemoglobin A1c
• Lipid profile
• Blood pressure
• Waist circumference and other indicators of metabolic risk

Depending on the individual, additional assessment may be appropriate.

Lifestyle interventions that improve metabolic health—including dietary changes, regular physical activity, weight management when indicated, and treatment of diabetes and other cardiovascular risk factors—can play an important role in managing MASLD.

2. Nutrition and Liver Health

The liver depends on adequate nutrition to carry out hundreds of metabolic functions, but it is important not to assume that a nutrient deficiency is the direct cause of elevated liver enzymes.

Nutritional status may still be relevant, particularly when a person has a restrictive diet, malabsorption, significant alcohol intake, or another condition affecting nutrient intake or absorption.

Rather than focusing on individual “liver detox” nutrients, a more evidence-based approach emphasizes an overall dietary pattern rich in:

• Vegetables and fruits
• Legumes
• Whole grains, when tolerated
• Nuts and seeds
• Extra virgin olive oil and other unsaturated fats
• Adequate protein
• Fish and other nutrient-dense foods

Mediterranean-style dietary patterns are frequently recommended for people with metabolic risk factors and MASLD.

3. Gut Health and the Gut-Liver Axis

The intestines and liver are closely connected through what is known as the gut-liver axis.

Blood from the gastrointestinal tract travels to the liver through the portal circulation, exposing the liver to nutrients, microbial products, and other substances originating in the gut.

Researchers are actively investigating how changes in the intestinal microbiome, intestinal barrier function, bile acid metabolism, and systemic inflammation may influence the development and progression of metabolic liver disease.

This is an evolving area of research.

While gut health may be one piece of the broader metabolic picture, claims that “healing the gut” alone will normalize liver enzymes or reverse liver disease go beyond the current evidence.

4. Medications and Supplements

Prescription medications, over-the-counter drugs, and dietary or herbal supplements can sometimes affect liver tests.

Potential contributors vary widely and may include certain:

• Antibiotics
• Antiseizure medications
• Antifungal medications
• Pain medications
• Herbal preparations
• Bodybuilding or weight-loss supplements
• Multi-ingredient dietary supplements

Acetaminophen can cause serious liver injury when taken in excessive amounts.

It is also important to put statins into perspective. Statins can occasionally cause mild elevations in liver enzymes, but serious liver injury from statins is rare. For many people with metabolic and cardiovascular risk—including many patients with MASLD—the cardiovascular benefits of statin therapy may substantially outweigh potential hepatic concerns.

Do not stop a prescribed medication simply because liver enzymes are elevated. Medication changes should be discussed with the prescribing healthcare professional.

It is equally important to tell your healthcare provider about all supplements and herbal products, not just prescription medications.

5. Alcohol and Elevated Liver Enzymes

Alcohol intake is another important consideration when evaluating abnormal liver tests.

The effect of alcohol varies according to the amount and pattern of consumption, individual susceptibility, metabolic health, medications, and underlying liver disease.

Alcohol and metabolic dysfunction can also coexist, potentially compounding liver risk.

If liver enzymes are persistently elevated, an accurate discussion of alcohol intake with your healthcare provider is an important part of determining the cause.

6. Sleep Apnea and Metabolic Liver Health

Obstructive sleep apnea is increasingly recognized as a potential contributor to metabolic dysfunction and may be associated with MASLD.

Repeated episodes of intermittent low oxygen during sleep may contribute to oxidative stress, inflammation, and metabolic dysregulation.

People with symptoms such as loud snoring, witnessed pauses in breathing, excessive daytime sleepiness, or other risk factors for sleep apnea should discuss appropriate evaluation with their healthcare provider.

Addressing sleep apnea is important for overall cardiovascular and metabolic health, not simply liver enzymes.

7. Other Causes of Elevated Liver Enzymes

Not every elevation in ALT or AST originates from metabolic liver disease.

Depending on the clinical picture, evaluation may need to consider:

• Hepatitis B or C
• Autoimmune hepatitis
• Hemochromatosis
• Wilson disease
• Alpha-1 antitrypsin deficiency
• Thyroid disease
• Celiac disease
• Muscle injury or strenuous exercise
• Gallbladder or bile duct disease

Because AST is also present in skeletal muscle, strenuous exercise or muscle injury can sometimes increase AST and, to a lesser extent, ALT.

This is another reason abnormal results need to be interpreted within the context of the whole person.

Understanding Other Liver Tests

ALT and AST are only part of a liver panel.

Other commonly measured markers include:

Alkaline phosphatase (ALP): Elevations may suggest a different pattern of liver or bile duct involvement, although ALP can also originate from bone and other tissues.

Gamma-glutamyl transferase (GGT): May help provide additional context when evaluating liver or biliary abnormalities.

Bilirubin: Elevated levels may occur with several liver, biliary, or blood-related conditions.

Albumin and INR: These can provide information about the liver's ability to perform important synthetic functions, particularly in more advanced disease.

Looking at the overall pattern can provide considerably more information than focusing on a single ALT or AST result.

What Should You Do If Your Liver Enzymes Are High?

A single mild elevation does not always indicate serious liver disease. Results can sometimes be influenced by recent illness, strenuous exercise, alcohol, medications, supplements, and other temporary factors.

However, persistent or unexplained abnormalities deserve appropriate evaluation.

Depending on your results and medical history, your healthcare provider may consider repeat bloodwork, additional laboratory testing, imaging, or assessment for liver fibrosis.

For people with suspected MASLD, noninvasive tools such as the FIB-4 score may be used to help assess the likelihood of advanced fibrosis and determine whether additional evaluation is warranted.

Lifestyle measures that support both liver and metabolic health may include:

• Following a Mediterranean-style or similarly nutrient-dense dietary pattern
• Engaging in regular physical activity
• Improving insulin sensitivity and glucose control
• Achieving sustainable weight reduction when medically appropriate
• Limiting or avoiding alcohol when indicated
• Addressing sleep apnea
• Reviewing medications and supplements with a healthcare professional
• Managing cholesterol, blood pressure, and other cardiovascular risk factors

Avoid starting aggressive “liver detox” programs or supplements simply because your liver enzymes are elevated. Some supplements marketed for detoxification or liver health can themselves cause liver injury.

When Elevated Liver Enzymes Need Prompt Medical Attention

Although mild elevations are common, seek prompt medical evaluation if abnormal liver tests occur alongside symptoms such as jaundice, dark urine, pale stools, significant abdominal pain or swelling, persistent vomiting, confusion, unusual bleeding, or severe weakness.

Markedly elevated liver enzymes also require timely medical evaluation, even when symptoms are minimal.

Key Points About Elevated Liver Enzymes

• Elevated liver enzymes are common and can have many different causes.
• ALT and AST indicate cellular injury or stress but do not, by themselves, measure how well the liver is functioning.
• MASLD and metabolic dysfunction are among the most common causes of persistent elevations.
• Normal ALT and AST do not necessarily rule out fatty liver disease or fibrosis.
• Alcohol, medications, supplements, viral infections, autoimmune conditions, hereditary disorders, and non-liver conditions should also be considered.
• An integrative approach can examine nutrition, metabolic health, sleep, medications, supplements, and lifestyle while still prioritizing appropriate medical evaluation.
• Persistent abnormalities should be investigated rather than attributed automatically to “toxins,” diet, or fatty liver.
• Supporting liver health is about addressing the underlying cause—not simply trying to lower a laboratory number.

Looking Beyond the Numbers

Elevated liver enzymes can provide an important clue about what may be happening within the liver or elsewhere in the body, but they are only one part of the picture.

An integrative approach considers conventional diagnostic evaluation alongside metabolic health, nutrition, medications and supplements, alcohol intake, sleep, physical activity, and other potential contributors.

The most important question is not simply, “How do I lower my liver enzymes?” but rather, “Why are they elevated?”

Identifying and addressing the underlying cause provides a much more meaningful foundation for protecting long-term liver and metabolic health.

If you have persistent or unexplained abnormal liver tests, speak with your healthcare provider about appropriate evaluation and follow-up.

💡 You may also enjoy:
• Chronic Inflammation and Health: How It Affects the Body
• Intentional Habits Over Resolutions: A More Sustainable Approach to Change
• Sleep Better: Acupuncture and Natural Remedies for Insomnia

References

• Huang, D.Q., Wong, V.W.S., Rinella, M.E. et al. (2025) ‘Metabolic dysfunction-associated steatotic liver disease in adults’, Nature Reviews Disease Primers, 11, 14. doi:10.1038/s41572-025-00599-1.

• Kwo, P.Y., Cohen, S.M. and Lim, J.K. (2017) ‘ACG clinical guideline: Evaluation of abnormal liver chemistries’, The American Journal of Gastroenterology, 112(1), pp. 18–35.

• Langan, R.C. and Hines-Smith, K.A. (2024) ‘Mildly elevated liver transaminase levels: Causes and evaluation’, American Family Physician, 110(6), pp. 585–591.

• Rinella, M.E., Neuschwander-Tetri, B.A., Siddiqui, M.S. et al. (2023) ‘AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease’, Hepatology, 77(5), pp. 1797–1835. doi:10.1097/HEP.0000000000000323.

• Tilg, H., Petta, S., Stefan, N. and Targher, G. (2026) ‘Metabolic dysfunction-associated steatotic liver disease in adults: A review’, JAMA, 335(2), pp. 163–174. doi:10.1001/jama.2025.19615.